Add to MyPages

This page will be saved to Cincinnati Children's MyPages, a collection of your favorite places. You can view, organize, or delete your favorites at any time.

 (optional)

E-mail this page

(All fields required)


Please enter a valid e-mail.

Please enter your name.

Please enter a valid e-mail.


Share this on:

Hematology

Significant Accomplishments

The Division of Hematology

The Division of Hematology was established in October 2010 as part of the newly formed Cancer and Blood Diseases Institute.   Clinton Joiner, MD, PhD, was named division director.  The division has nine faculty members and encompasses two comprehensive treatment centers for sickle cell disease and bleeding disorders.  In addition, division faculty members care for numerous patients with rare blood disorders.  We also have strong research collaborations with the Division of Experimental Hematology and Cancer Biology and maintain a portfolio of basic, translational and clinical research studies. 

Center of Excellence in Molecular Hematology

The Divisions of Hematology and Experimental Hematology received a major award from the National Institutes of Health as a Center of Excellence in Molecular Hematology.  One of six such programs in the country funded by the National Institute of Diabetes and Digestive and Kidney Diseases, the center provides core services to laboratories studying hematopoiesis and blood disorders, as well as enrichment programs and pilot funding to facilitate hematology research.  Funding for the center exceeds $3.5 million over five years.  Clinton Joiner, MD, PhD, serves as codirector of the center.  

National and International Faculty Activities

The national and international reputations of the hematology faculty are reflected in their professional activities.  Clinton Joiner, MD, PhD, was invited to present a plenary address to the First Global Conference on Sickle Cell Disease in Accra, Ghana, in July 2010.  Joseph Palumbo, MD, was an invited speaker at the 10th International Congress on Inflammation in Paris in June 2011 and at the national meeting of the Federation of American Societies of Experimental Biology.  Charles Quinn, MD, presented at World Sickle Cell Disease Awareness Day, sponsored by the Centers for Disease Control in Atlanta in June 2011.  Theodosia Kalfa, MD, PhD, was invited to speak in September 2011 at an international symposium in Paris organized by the French Institut National de la Transfusion Sanguine.